Clinical Trial Update: Abnormal Expression Proteins, Mitochondrial DNA and miRNA of Irritable Bowel Syndrome

View source ↗

Summary

Clinical trial update examining abnormal expression proteins, mitochondrial DNA, and miRNA in Irritable Bowel Syndrome, with the trial status listed as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Irritable Bowel Syndrome, Digestive System Diseases | Status: UNKNOWN